Faculty Have Experienced Allies In Tech-Transfer Process

MARKET FORCE: Harvard's Joyce Brinton says tech-transfer officers are best equipped to determine what has commercial potential. Technology-transfer professionals have a simple piece of advice for new faculty members who believe their ideas have commercial potential but who have never brought products to the market: Get help-immediately. "Call your friendly technology-transfer office if you've got a good idea," urges Joyce Brinton, director of Harvard University's Office for Technology and Trad

Written byThomas Durso
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share


MARKET FORCE: Harvard's Joyce Brinton says tech-transfer officers are best equipped to determine what has commercial potential.
Technology-transfer professionals have a simple piece of advice for new faculty members who believe their ideas have commercial potential but who have never brought products to the market: Get help-immediately.

"Call your friendly technology-transfer office if you've got a good idea," urges Joyce Brinton, director of Harvard University's Office for Technology and Trademark Licensing. "That way, they can get some feedback from someone who knows not only the institution's policies, but also something about the kinds of ideas that in fact will have some commercial potential and therefore will offer a potential for tech transfer."

Technology transfer is the process by which new inventions and technologies go from ideas in the laboratory to being sold on the market. The process usually involves patenting one's innovation, but according to Brinton and her counterparts at ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies